597 filings
ARS
2023 FY
SYRE
Spyre Therapeutics Inc.
2 Apr 24
Annual report to shareholders
4:36pm
EFFECT
SYRE
Spyre Therapeutics Inc.
2 Apr 24
Notice of effectiveness
12:15am
EFFECT
SYRE
Spyre Therapeutics Inc.
2 Apr 24
Notice of effectiveness
12:15am
DEF 14A
SYRE
Spyre Therapeutics Inc.
Definitive proxy
1 Apr 24
4:06pm
POS AM
SYRE
Spyre Therapeutics Inc.
26 Mar 24
Prospectus update (post-effective amendment)
6:30pm
PRE 14A
SYRE
Spyre Therapeutics Inc.
Preliminary proxy
20 Mar 24
7:14am
424B3
SYRE
Spyre Therapeutics Inc.
18 Mar 24
Prospectus supplement
4:06pm
8-K
SYRE
Spyre Therapeutics Inc.
18 Mar 24
Spyre Therapeutics Announces $180 Million Private Placement
8:31am
POS AM
SYRE
Spyre Therapeutics Inc.
14 Mar 24
Prospectus update (post-effective amendment)
4:12pm
S-1/A
SYRE
Spyre Therapeutics Inc.
IPO registration (amended)
14 Mar 24
4:10pm
SC 13G/A
SYRE
Spyre Therapeutics Inc.
11 Mar 24
Spyre Therapeutics / FMR ownership change
8:19am
POS AM
SYRE
Spyre Therapeutics Inc.
5 Mar 24
Prospectus update (post-effective amendment)
5:15pm
S-1/A
SYRE
Spyre Therapeutics Inc.
IPO registration (amended)
1 Mar 24
4:15pm
S-8
SYRE
Spyre Therapeutics Inc.
29 Feb 24
Registration of securities for employees
5:06pm
8-K
SYRE
Spyre Therapeutics Inc.
29 Feb 24
Spyre Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
4:14pm
10-K
2023 FY
SYRE
Spyre Therapeutics Inc.
Annual report
29 Feb 24
4:07pm
4
Turtle Cameron
20 Feb 24
Spyre Therapeutics / Cameron Turtle ownership change
9:21pm
SC 13G/A
Venrock Healthcare Capital Partners III, L.P.
14 Feb 24
Spyre Therapeutics / Venrock Healthcare Capital Partners III ownership change
8:47pm
SC 13G/A
SYRE
Spyre Therapeutics Inc.
14 Feb 24
Spyre Therapeutics / Nantahala Capital Management ownership change
4:51pm